idarubicin has been researched along with l 778,123 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dallmann, I; Ganser, A; Morgan, MA; Onono, FO; Reuter, CW; Scherr, M; Spielmann, HP; Subramanian, T; Venturini, L | 1 |
1 other study(ies) available for idarubicin and l 778,123
Article | Year |
---|---|
Modulation of anthracycline-induced cytotoxicity by targeting the prenylated proteome in myeloid leukemia cells.
Topics: Anthracyclines; Antigens, Neoplasm; Apoptosis; Benzodiazepines; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Dimethylallyltranstransferase; DNA Topoisomerases, Type II; DNA-Binding Proteins; Drug Synergism; Farnesyltranstransferase; Gene Expression Regulation, Neoplastic; Humans; Idarubicin; Imidazoles; Leukemia, Myeloid; MAP Kinase Signaling System; Poly-ADP-Ribose Binding Proteins; Protein Prenylation | 2012 |